MDR gene therapy (Ingenex)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMDR gene therapy (Ingenex)
Drug Alias NameMDRx1
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Peripheral blood stem cell therapy
Mechanisms of ActionAnticancer multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIngenex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIngenex Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A